Borosil Scientific reported a consolidated profit of Rs 9.66 crore for the half-year ending September 2026, marking a turnaround from the loss reported in the same period last year. Revenue rose to Rs 221.72 crore. The company also announced a strategic Rs 70 crore investment in a new glass tubing furnace at its Bharuch plant, expected to be operational by March 2028 to boost backward integration and supply-chain efficiency.
Borosil Scientific Q2 Financial Turnaround and Strategic Expansion
Consolidated profit reached Rs 9.66 crore for the half-year ended September 30, 2026, compared to a loss of Rs 1.36 crore in the previous year.
Revenue from operations climbed to Rs 221.72 crore, reflecting a consistent growth trajectory for the company.
Reader Takeaway: Profit turnaround driven by growth; Rs 70 crore furnace project boosts long-term cost optimization and supply-chain independence.
What just happened
Borosil Scientific has marked a financial turnaround, shifting from a loss-making position to a consolidated profit of Rs 9.66 crore for the six months ending September 2026. Standalone performance was also strong, with profits rising to Rs 13.09 crore. Alongside these numbers, the company announced a major capital expenditure project: a Borosilicate 3.3 glass tubing furnace at its Bharuch facility. The project, valued at Rs 70 crore, aims for a daily capacity of 20 metric tonnes and is expected to start production by March 2028.
Why this matters
This expansion is a significant step toward backward integration. By producing its own glass tubing, Borosil Scientific intends to reduce its reliance on imports, stabilize its supply chain, and improve margins by optimizing manufacturing costs. The output is intended primarily for captive use, with any surplus to be sold externally. The company is also positioning itself to leverage subsidies under the Viksit Gujarat Industrial Policy 2026.
Operational Changes
Effective this quarter, the company has reorganized its internal reporting structure. The Chief Operating Decision Maker now reviews performance across three distinct segments: Scientific (Laboratory Glass & Equipment and Process System), Primary Pharma Packaging, and Consumer Glassware, providing more clarity on the growth drivers of each business vertical.
Risks to watch
Investors should monitor the funding mix for the new Rs 70 crore furnace. While the company stated it will use internal accruals and/or borrowings, the extent of new debt taken on will impact the balance sheet. Additionally, the project timeline stretches to 2028, leaving execution risk as a long-term factor.
Context metrics
Revenue for the consolidated half-year grew to Rs 221.72 crore from Rs 202.88 crore in the year-ago period. Standalone revenue similarly increased to Rs 204.09 crore, up from Rs 188.49 crore during the same period in 2025.